Optical molecular imaging in drug discovery and clinical development

Area of Science:

• Biomedical imaging
• Drug discovery and development
• Molecular imaging technologies

Background:

• Advancements in genomics, combinatorial chemistry, and high-throughput screening have identified numerous novel drug targets.
• The increasing number of drug candidates necessitates improved in vivo measurement methodologies and animal models.
• Translational biomarkers are crucial for facilitating the clinical evaluation of promising drug molecules.

Purpose of the Study:

• To review optical molecular imaging technology.
• To explore its integration into various therapeutic areas.
• To discuss its impact on preclinical drug discovery and potential clinical applications.

Main Methods:

• Focus on optical molecular imaging techniques.
• Review of integration in preclinical drug discovery workflows.
• Discussion of translational biomarker development using imaging.

Main Results:

• Optical molecular imaging is increasingly integrated into preclinical drug discovery.
• The technology provides valuable translational biomarkers.
• Potential clinical applications are being explored.

Conclusions:

• Optical molecular imaging is a valuable tool for modern drug discovery.
• It addresses challenges in evaluating novel drug candidates.
• Its translational potential facilitates clinical translation.